|
| 36725935 | Single-cell spatial immune landscapes of primary and metastatic brain tumours. | Nature | 2023 |
| 37774329 | Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. | J Clin Oncol | 2023 |
| 37345142 | Multi-Omic Analysis of CIC's Functional Networks Reveals Novel Interaction Partners and a Potential Role in Mitotic Fidelity. | Cancers (Basel) | 2023 |
| 37208512 | Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas. | Br J Cancer | 2023 |
| 37017232 | Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care. | Endocr Relat Cancer | 2023 |
| 36634297 | Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. | JCO Precis Oncol | 2023 |
| 37255328 | Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting. | J Natl Cancer Inst | 2023 |
| 37184955 | Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms. | Endocr Relat Cancer | 2023 |
| 37244935 | macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma. | Nat Commun | 2023 |
| 36738541 | Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours - A systematic review and meta-analysis. | Eur J Cancer | 2023 |
| 36725935 | Single-cell spatial immune landscapes of primary and metastatic brain tumours. | Nature | 2023 |
| 37774329 | Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. | J Clin Oncol | 2023 |
| 37255328 | Consensus report of the 2021 National Cancer Institute neuroendocrine tumor clinical trials planning meeting. | J Natl Cancer Inst | 2023 |
| 37184955 | Expert Consensus Practice Recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms. | Endocr Relat Cancer | 2023 |
| 37017232 | Practical considerations when providing palliative care to patients with neuroendocrine tumors in the context of routine disease management or hospice care. | Endocr Relat Cancer | 2023 |
| 37345142 | Multi-Omic Analysis of CIC's Functional Networks Reveals Novel Interaction Partners and a Potential Role in Mitotic Fidelity. | Cancers (Basel) | 2023 |
| 37244935 | macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma. | Nat Commun | 2023 |
| 37208512 | Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomas. | Br J Cancer | 2023 |
| 36738541 | Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours - A systematic review and meta-analysis. | Eur J Cancer | 2023 |
| 36634297 | Programmatic Precision Oncology Decision Support for Patients With Gastrointestinal Cancer. | JCO Precis Oncol | 2023 |
| 34027579 | COVID-19's Impact on Cancer Care: Increased Emotional Stress in Patients and High Risk of Provider Burnout. | J Gastrointest Surg | 2022 |
| 36178522 | The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers. | Acta Neuropathol | 2022 |
| 35835937 | Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression. | Commun Biol | 2022 |
| 35425901 | High replication stress and limited Rad51-mediated DNA repair capacity, but not oxidative stress, underlie oligodendrocyte precursor cell radiosensitivity. | NAR Cancer | 2022 |
| 35737232 | Processing and Cryopreservation of Blood, Cancer Tissues, and Cancer Cells for Viable Biobanking. | Methods Mol Biol | 2022 |
| 36131014 | Failure of human rhombic lip differentiation underlies medulloblastoma formation. | Nature | 2022 |
| 35731023 | SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma. | Endocr Relat Cancer | 2022 |
| 36395401 | A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine Tumors. | Pancreas | 2022 |
| 36446943 | Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation. | Nature | 2022 |
| 37600107 | Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study. | Ann Surg Open | 2022 |
| 34027579 | COVID-19's Impact on Cancer Care: Increased Emotional Stress in Patients and High Risk of Provider Burnout. | J Gastrointest Surg | 2022 |
| 35045527 | Medical management of gastrointestinal neuroendocrine tumors. | Curr Opin Endocrinol Diabetes Obes | 2022 |
| 34819303 | Hi-C detects genomic structural variants in peripheral blood of pediatric leukemia patients. | Cold Spring Harb Mol Case Stud | 2022 |
| 35303420 | Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity. | Cancer Cell | 2022 |
| 35324465 | Everolimus with or without bevacizumab in advanced pNET: CALGB 80701 (Alliance). | Endocr Relat Cancer | 2022 |
| 37600107 | Benefit of Primary Tumor Resection in Stage IV, Grade 1 and 2, Pancreatic Neuroendocrine Tumors: A Propensity-Score Matched Cohort Study. | Ann Surg Open | 2022 |
| 35737232 | Processing and Cryopreservation of Blood, Cancer Tissues, and Cancer Cells for Viable Biobanking. | Methods Mol Biol | 2022 |
| 35835937 | Combined MEK and JAK/STAT3 pathway inhibition effectively decreases SHH medulloblastoma tumor progression. | Commun Biol | 2022 |
| 35731023 | SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma. | Endocr Relat Cancer | 2022 |
| 35425901 | High replication stress and limited Rad51-mediated DNA repair capacity, but not oxidative stress, underlie oligodendrocyte precursor cell radiosensitivity. | NAR Cancer | 2022 |
| 36446943 | Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation. | Nature | 2022 |
| 36178522 | The proteomic landscape of glioblastoma recurrence reveals novel and targetable immunoregulatory drivers. | Acta Neuropathol | 2022 |
| 36131014 | Failure of human rhombic lip differentiation underlies medulloblastoma formation. | Nature | 2022 |
| 36395401 | A Phase II Study of Ziv-Aflibercept in Patients With Advanced Extrapancreatic Neuroendocrine Tumors. | Pancreas | 2022 |
| 35045527 | Medical management of gastrointestinal neuroendocrine tumors. | Curr Opin Endocrinol Diabetes Obes | 2022 |
| 35303420 | Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity. | Cancer Cell | 2022 |
| 35324465 | Everolimus with or without bevacizumab in advanced pNET: CALGB 80701 (Alliance). | Endocr Relat Cancer | 2022 |
| 34819303 | Hi-C detects genomic structural variants in peripheral blood of pediatric leukemia patients. | Cold Spring Harb Mol Case Stud | 2022 |
| 32925400 | Neuroimaging and Pathology Findings Associated With Rapid Onset Obesity, Hypothalamic Dysfunction, Hypoventilation, and Autonomic Dysregulation (ROHHAD) Syndrome. | J Pediatr Hematol Oncol | 2021 |
| 33640871 | Ribociclib and everolimus in well-differentiated foregut neuroendocrine tumors. | Endocr Relat Cancer | 2021 |